Loading clinical trials...
Loading clinical trials...
A Prospective, Open Label, Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients
Conditions
Interventions
HepaStem Infusion
Locations
1
South Korea
Samsung Medical Center
Seoul, South Korea
Start Date
July 12, 2018
Primary Completion Date
November 4, 2020
Completion Date
November 4, 2020
Last Updated
November 6, 2020
NCT06805695
NCT06953505
NCT06664840
NCT00947544
NCT00992459
NCT05330039
Lead Sponsor
HLB Cell Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions